Effects of insulin on the vasculature.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Vascular Pharmacology

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/157016111795495558PMID 20807190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pioglitazone modulates the balance of effector and regulatory T cells in apolipoprotein E deficient mice.

  2011cited by this paper
• Proinflammatory and Prothrombotic Effects of Hypoglycemia

  2010cited by this paper
• Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice.

  2010cited by this paper
• Postprocedure Administration of Insulin in Canine Autologous Vein Grafting: A Potential Strategy to Attenuate Intimal Hyperplasia

  2010cited by this paper
• Critics press FDA to act on evidence of rosiglitazone's cardiac safety issues.

  2010cited by this paper
• Insulin Inhibits and Oral Sucrose Increases Neointimal Growth after Arterial Injury in Rats

  2010cited by this paper
• The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

  2010cited by this paper
• Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population

  2010cited by this paper
• Absence of Akt1 Reduces Vascular Smooth Muscle Cell Migration and Survival and Induces Features of Plaque Vulnerability and Cardiac Dysfunction During Atherosclerosis

  2009cited by this paper
• New Mechanism of Rosiglitazone to Reduce Neointimal Hyperplasia: Activation of Glycogen Synthase Kinase-3&bgr; Followed by Inhibition of MMP-9

  2009cited by this paper
• Chronic insulin treatment suppresses PTP1B function, induces increased PDGF signaling, and amplifies neointima formation in the balloon-injured rat artery.

  2009cited by this paper
• Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress

  2009cited by this paper
• Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials.

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As

  2009cited by this paper
• Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study

  2009cited by this paper
• Insulin Increases Reendothelialization and Inhibits Cell Migration and Neointimal Growth After Arterial Injury

  2009cited by this paper
• An increase in HbA1c after percutaneous coronary intervention raises the risk for restenosis in patients without Type 2 diabetes mellitus

  2008cited by this paper
• Metformin: Effects on Micro and Macrovascular Complications in Type 2 Diabetes

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• METFORMIN, ARTERIAL FUNCTION, INTIMA–MEDIA THICKNESS AND NITROXIDATION IN METABOLIC SYNDROME: THE MEFISTO STUDY

  2008cited by this paper
• Molecular Mechanisms of Atherosclerosis in Metabolic Syndrome: Role of Reduced IRS2-Dependent Signaling

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Rosiglitazone promotes atherosclerotic plaque stability in fat-fed ApoE-knockout mice.

  2008cited by this paper
• Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients.

  2008cited by this paper
• Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice.

  2007cited by this paper
• Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study

  2007cited by this paper
• Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

  2007cited by this paper
• Angiographic and Clinical Outcomes of Rosiglitazone in Patients With Type 2 Diabetes Mellitus After Percutaneous Coronary Interventions: A Single Center Experience

  2007cited by this paper
• Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.

  2007cited by this paper
• Preprocedure hyperglycemia is more strongly associated with restenosis in diabetic patients after percutaneous coronary intervention than is hemoglobin A1C.

  2007cited by this paper
• IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atherosclerosis Progression in ApoE-Deficient Mice

  2007cited by this paper
• Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease.

  2007cited by this paper
• Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study.

  2007cited by this paper
• The role of vascular stem cells in atherogenesis and post-angioplasty restenosis.

  2007cited by this paper
• Relationship Between Metabolic Risk Factor Clustering and Cardiovascular Mortality Stratified by High Blood Glucose and Obesity

  2007cited by this paper
• Genetic Deletion of Pregnancy-Associated Plasma Protein-A Is Associated With Resistance to Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice Challenged With a High-Fat Diet

  2007cited by this paper
• Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

  2007cited by this paper
• Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease.

  2007cited by this paper
• Insulin stimulates arterial neointima formation in normal rats after balloon injury

  2006cited by this paper
• Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions.

  2006cited by this paper
• A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes.

  2006cited by this paper
• Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

  2006cited by this paper
• Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase.

  2006cited by this paper
• Preventing Cardiovascular Disease and Diabetes

  2006cited by this paper
• Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)

  2006cited by this paper
• Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis.

  2006cited by this paper
• Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway

  2005cited by this paper
• Vascular Neointimal Formation and Signaling Pathway Activation in Response to Stent Injury in Insulin-Resistant and Diabetic Animals

  2005cited by this paper
• Attenuation of Accumulation of Neointimal Lipid by Pioglitazone in Mice Genetically Deficient in Insulin Receptor Substrate-2 and Apolipoprotein E

  2005cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials

  2005cited by this paper
• Anti-Atherogenic Effect of Insulin in vivo

  2005cited by this paper
• Mathematical modeling of the nitric oxide/cGMP pathway in the vascular smooth muscle cell.

  2005cited by this paper
• The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

  2005cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

  2005cited by this paper
• Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.

  2005cited by this paper
• Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes.

  2004cited by this paper
• Dominant negative insulin-like growth factor-1 receptor inhibits neointimal formation through suppression of vascular smooth muscle cell migration and proliferation, and induction of apoptosis.

  2004cited by this paper
• Neointimal proliferation within carotid stents is more pronounced in diabetic patients with initial poor glycaemic state

  2004cited by this paper
• Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy

  2004cited by this paper
• Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is associated with increased nuclear factor-kappaB and activator protein-1 activity.

  2004cited by this paper
• One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial

  2004cited by this paper
• Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.

  2004cited by this paper
• Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

  2004cited by this paper
• The Evolving Diabetes Burden in the United States

  2004cited by this paper
• Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention.

  2004cited by this paper
• Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

  2004cited by this paper
• Oxidative Stress Activates the Plasminogen Activator Inhibitor Type 1 (PAI-1) Promoter through an AP-1 Response Element and Cooperates with Insulin for Additive Effects on PAI-1 Transcription*

  2004cited by this paper
• Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance.

  2003cited by this paper
• Oral Insulin Supplementation Attenuates Atherosclerosis Progression in Apolipoprotein E-Deficient Mice

  2003cited by this paper
• Nitric Oxide and Cyclic GMP Increase the Expression of Matrix Metalloproteinase-9 in Vascular Smooth Muscle

  2003cited by this paper
• Association of Insulin Resistance, Hyperleptinemia, and Impaired Nitric Oxide Release With In-Stent Restenosis in Patients Undergoing Coronary Stenting

  2003cited by this paper
• Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways.

  2003cited by this paper
• The role of intramuscular lipid in insulin resistance.

  2003cited by this paper
• Insulin-Stimulated Cyclic Guanosine Monophosphate Inhibits Vascular Smooth Muscle Cell Migration by Inhibiting Ca/Calmodulin-Dependent Protein Kinase II

  2003cited by this paper
• Migration of adventitial myofibroblasts following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries.

  2003cited by this paper
• Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9.

  2003cited by this paper
• The metabolic syndrome.

  2003cited by this paper
• Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury

  2003cited by this paper
• Intimal hyperplasia following carotid endarterectomy in an insulin-resistant rat model.

  2003cited by this paper
• Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations.

  2002cited by this paper
• Coronary Bypass Graft Patency in Patients With Diabetes in the Bypass Angioplasty Revascularization Investigation (BARI)

  2002cited by this paper
• Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells

  2002cited by this paper
• A central role for JNK in obesity and insulin resistance

  2002cited by this paper
• Inhibition of Platelet‐Collagen Interaction An In Vivo Action of Insulin Abolished by Insulin Resistance in Obesity

  2002cited by this paper
• Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus.

  2002cited by this paper
• Insulin inhibits PDGF-directed VSMC migration via NO/ cGMP increase of MKP-1 and its inactivation of MAPKs.

  2002cited by this paper
• Smooth-muscle progenitor cells of bone marrow origin contribute to the development of neointimal thickenings in rat aortic allografts and injured rat carotid arteries1

  2002cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

  2001cited by this paper
• Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells.

  2001cited by this paper
• Effects of Balloon Injury on Neointimal Hyperplasia in Streptozotocin-Induced Diabetes and in Hyperinsulinemic Nondiabetic Pancreatic Islet–Transplanted Rats

  2001cited by this paper
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper
• Insulin-stimulated Activation of eNOS Is Independent of Ca2+ but Requires Phosphorylation by Akt at Ser1179 *

  2001cited by this paper
• Molecular mechanisms of ATP and insulin synergistic stimulation of coronary artery smooth muscle growth.

  2001cited by this paper
• Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Study (ARTS) Trial

  2001cited by this paper
• Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice

  2001cited by this paper

• The triglyceride-glucose index: updating evidence from clinical settings to molecular mechanisms in ageing-related cerebrovascular diseases

  2025cites this paper
• Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments

  2025cites this paper
• Cellular and Molecular Mechanisms of VSMC Phenotypic Switching in Type 2 Diabetes

  2025cites this paper
• DASH Diet Versus Intermittent Fasting on Insulin Resistance in NAFLD Patients

  2024cites this paper
• Resveratrol Inhibits Insulin-Induced Vascular Smooth Muscle Cell Proliferation and Migration by Activating SIRT1

  2022cites this paper
• Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study.

  2021cites this paper
• Network Pharmacology and Experimental Verification Reveal an Protective Role of Jiedu Tongluo Tiaogan Formula on INS-1 Cells and HepG2 Cells From High Glucose-mediated Injury via the PI3K/Akt Pathways

  2021cites this paper
• Decoding the chemical composition and pharmacological mechanisms of Jiedu Tongluo Tiaogan Formula using high-performance liquid chromatography coupled with network pharmacology-based investigation

  2021cites this paper
• Roles of vascular endothelial and smooth muscle cells in the vasculoprotective effect of insulin in a mouse model of restenosis

  2021cites this paper
• Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat diet

  2020cites this paper
• Pathogenesis of atherosclerosis in peripheral artery disease for diabetes patients

  2020cites this paper
• Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus

  2019cites this paper
• Upregulated 14‑3‑3β aggravates restenosis by promoting cell migration following vascular injury in diabetic rats with elevated levels of free fatty acids.

  2018influential citation
• Cadherins in vascular smooth muscle cell (patho)biology: Quid nos scimus?

  2018cites this paper
• Insulin resistance in obesity: an overview of fundamental alterations

  2018cites this paper
• Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.

  2018cites this paper
• The role of FGF21 in regulating energy homeostasis

  2017cites this paper
• Baseline glycemic status and mortality in 241,499 Korean metropolitan subjects: A Kangbuk Samsung Health Study.

  2016cites this paper
• Nutrition in Metabolic Syndrome Topic 24 Module 24 . 2 Insulin Resistance : from Pathophysiology to Clinical Assessment

  2016cites this paper
• The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1β, IL-6 and IL-10 Secretion

  2016cites this paper
• Association between insulin dosage and insulin usage time, and coronary artery lesions in patients with type 2 diabetes and coronary heart disease

  2016cites this paper
• High-dose insulin inhibits gap junction intercellular communication in vascular smooth muscle cells.

  2015cites this paper
• Mechanism and significance of adipose inflammatory recruitment

  2015cites this paper
• Cardiovascular disease in diabetes mellitus: risk factors and medical therapy.

  2014cites this paper
• Differential Metabolic Actions of Specific Statins: Clinical and Therapeutic Considerations

  2014cites this paper
• Correlation between single nucleotide polymorphisms of the ACTA2 gene and coronary artery stenosis in patients with type 2 diabetes mellitus

  2014cites this paper
• Insulin resistance is associated with coronary plaque vulnerability: insight from optical coherence tomography analysis.

  2014cites this paper
• Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance

  2014cites this paper
• Small artery remodeling in obesity and insulin resistance.

  2014cites this paper
• Smooth muscle cell phenotypic switching and diabetic angiopathies

  2014cites this paper
• Clinical biomarkers in metabolic syndrome.

  2014cites this paper
• Nutrition in Metabolic Syndrome

  2013cites this paper
• Implication of insulin receptor A isoform and IRA/IGF-IR hybrid receptors in the aortic vascular smooth muscle cell proliferation: role of TNF-α and IGF-II.

  2013cites this paper
• Implications of autophagy for vascular smooth muscle cell function and plasticity.

  2013cites this paper
• Aktuelles zur diabetischen Makroangiopathie

  2012cites this paper
• Impact of metabolic syndrome on re-stenosis development: Role of drug-eluting stents

  2012cites this paper
• Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification.

  2012cites this paper
• Glucose-lowering interventions and risk assessment in patients with coronary heart disease and disturbed glucose metabolism

  2012cites this paper
• Effect of the α-glucosidase inhibitor miglitol on the glucose profile in Japanese type 2 diabetic patients receiving multiple daily insulin injections.

  2012cites this paper
• Myocardial regeneration: the role of progenitor cells derived from bone marrow and heart.

  2012cites this paper
• Targeting type 2 diabetes.

  2011cites this paper
• Vascular smooth-muscle-cell activation: proteomics point of view.

  2011cites this paper